mRNA Vaccines for Infectious Diseases Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global mRNA Vaccines for Infectious Diseases Market Perspective (2017-2028)
2.2 mRNA Vaccines for Infectious Diseases Growth Trends by Region
2.2.1 mRNA Vaccines for Infectious Diseases Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 mRNA Vaccines for Infectious Diseases Historic Market Size by Region (2017-2022)
2.2.3 mRNA Vaccines for Infectious Diseases Forecasted Market Size by Region (2023-2028)
2.3 mRNA Vaccines for Infectious Diseases Market Dynamics
2.3.1 mRNA Vaccines for Infectious Diseases Industry Trends
2.3.2 mRNA Vaccines for Infectious Diseases Market Drivers
2.3.3 mRNA Vaccines for Infectious Diseases Market Challenges
2.3.4 mRNA Vaccines for Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Vaccines for Infectious Diseases Players by Revenue
3.1.1 Global Top mRNA Vaccines for Infectious Diseases Players by Revenue (2017-2022)
3.1.2 Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Players (2017-2022)
3.2 Global mRNA Vaccines for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Vaccines for Infectious Diseases Revenue
3.4 Global mRNA Vaccines for Infectious Diseases Market Concentration Ratio
3.4.1 Global mRNA Vaccines for Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccines for Infectious Diseases Revenue in 2021
3.5 mRNA Vaccines for Infectious Diseases Key Players Head office and Area Served
3.6 Key Players mRNA Vaccines for Infectious Diseases Product Solution and Service
3.7 Date of Enter into mRNA Vaccines for Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Vaccines for Infectious Diseases Breakdown Data by Type
4.1 Global mRNA Vaccines for Infectious Diseases Historic Market Size by Type (2017-2022)
4.2 Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Type (2023-2028)
5 mRNA Vaccines for Infectious Diseases Breakdown Data by Application
5.1 Global mRNA Vaccines for Infectious Diseases Historic Market Size by Application (2017-2022)
5.2 Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
6.2 North America mRNA Vaccines for Infectious Diseases Market Size by Type
6.2.1 North America mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
6.2.2 North America mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
6.2.3 North America mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
6.3 North America mRNA Vaccines for Infectious Diseases Market Size by Application
6.3.1 North America mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
6.3.2 North America mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
6.3.3 North America mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
6.4 North America mRNA Vaccines for Infectious Diseases Market Size by Country
6.4.1 North America mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
6.4.2 North America mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
7.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Type
7.2.1 Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
7.2.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
7.2.3 Europe mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
7.3 Europe mRNA Vaccines for Infectious Diseases Market Size by Application
7.3.1 Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
7.3.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
7.3.3 Europe mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
7.4 Europe mRNA Vaccines for Infectious Diseases Market Size by Country
7.4.1 Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
7.4.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
8.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Type
8.2.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
8.2.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
8.2.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
8.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Application
8.3.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
8.3.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
8.3.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
8.4 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region
8.4.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2022)
8.4.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
9.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Type
9.2.1 Latin America mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
9.2.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
9.2.3 Latin America mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
9.3 Latin America mRNA Vaccines for Infectious Diseases Market Size by Application
9.3.1 Latin America mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
9.3.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
9.3.3 Latin America mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
9.4 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country
9.4.1 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
9.4.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
10.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type
10.2.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
10.2.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
10.2.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
10.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application
10.3.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
10.3.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
10.3.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
10.4 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country
10.4.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
10.4.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.1.5 Moderna Therapeutics Recent Developments
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Vaccines for Infectious Diseases Introduction
11.2.4 CureVac Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.2.5 CureVac Recent Developments
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Introduction
11.3.4 Translate Bio Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.3.5 Translate Bio Recent Developments
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Vaccines for Infectious Diseases Introduction
11.4.4 BioNTech Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.4.5 BioNTech Recent Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.5.5 Sangamo Therapeutics Recent Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.6.5 Argos Therapeutics Recent Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Introduction
11.7.4 In-Cell-Art Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.7.5 In-Cell-Art Recent Developments
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Introduction
11.8.4 eTheRNA Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.8.5 eTheRNA Recent Developments
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Vaccines for Infectious Diseases Introduction
11.9.4 Ethris Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.9.5 Ethris Recent Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.10.5 Tiba Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Infectious Disease Vaccines
Table 3. Key Players of Cancer Vaccines
Table 4. Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global mRNA Vaccines for Infectious Diseases Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global mRNA Vaccines for Infectious Diseases Market Share by Region (2017-2022)
Table 8. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global mRNA Vaccines for Infectious Diseases Market Share by Region (2023-2028)
Table 10. mRNA Vaccines for Infectious Diseases Market Trends
Table 11. mRNA Vaccines for Infectious Diseases Market Drivers
Table 12. mRNA Vaccines for Infectious Diseases Market Challenges
Table 13. mRNA Vaccines for Infectious Diseases Market Restraints
Table 14. Global mRNA Vaccines for Infectious Diseases Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global mRNA Vaccines for Infectious Diseases Revenue Share by Players (2017-2022)
Table 16. Global Top mRNA Vaccines for Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Infectious Diseases as of 2021)
Table 17. Ranking of Global Top mRNA Vaccines for Infectious Diseases Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by mRNA Vaccines for Infectious Diseases Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players mRNA Vaccines for Infectious Diseases Product Solution and Service
Table 21. Date of Enter into mRNA Vaccines for Infectious Diseases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Type (2017-2022)
Table 25. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Type (2023-2028)
Table 27. Global mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global mRNA Vaccines for Infectious Diseases Revenue Share by Application (2017-2022)
Table 29. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global mRNA Vaccines for Infectious Diseases Revenue Share by Application (2023-2028)
Table 31. North America mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 61. Moderna Therapeutics Company Details
Table 62. Moderna Therapeutics Business Overview
Table 63. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product
Table 64. Moderna Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million)
Table 65. Moderna Therapeutics Recent Developments
Table 66. CureVac Company Details
Table 67. CureVac Business Overview
Table 68. CureVac mRNA Vaccines for Infectious Diseases Product
Table 69. CureVac Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million)
Table 70. CureVac Recent Developments
Table 71. Translate Bio Company Details
Table 72. Translate Bio Business Overview
Table 73. Translate Bio mRNA Vaccines for Infectious Diseases Product
Table 74. Translate Bio Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million)
Table 75. Translate Bio Recent Developments
Table 76. BioNTech Company Details
Table 77. BioNTech Business Overview
Table 78. BioNTech mRNA Vaccines for Infectious Diseases Product
Table 79. BioNTech Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million)
Table 80. BioNTech Recent Developments
Table 81. Sangamo Therapeutics Company Details
Table 82. Sangamo Therapeutics Business Overview
Table 83. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product
Table 84. Sangamo Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million)
Table 85. Sangamo Therapeutics Recent Developments
Table 86. Argos Therapeutics Company Details
Table 87. Argos Therapeutics Business Overview
Table 88. Argos Therapeutics mRNA Vaccines for Infectious Diseases Product
Table 89. Argos Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million)
Table 90. Argos Therapeutics Recent Developments
Table 91. In-Cell-Art Company Details
Table 92. In-Cell-Art Business Overview
Table 93. In-Cell-Art mRNA Vaccines for Infectious Diseases Product
Table 94. In-Cell-Art Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million)
Table 95. In-Cell-Art Recent Developments
Table 96. eTheRNA Company Details
Table 97. eTheRNA Business Overview
Table 98. eTheRNA mRNA Vaccines for Infectious Diseases Product
Table 99. eTheRNA Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million)
Table 100. eTheRNA Recent Developments
Table 101. Ethris Company Details
Table 102. Ethris Business Overview
Table 103. Ethris mRNA Vaccines for Infectious Diseases Product
Table 104. Ethris Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million)
Table 105. Ethris Recent Developments
Table 106. Tiba Biotechnology Company Details
Table 107. Tiba Biotechnology Business Overview
Table 108. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product
Table 109. Tiba Biotechnology Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million)
Table 110. Tiba Biotechnology Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Vaccines for Infectious Diseases Market Share by Type: 2021 VS 2028
Figure 2. Infectious Disease Vaccines Features
Figure 3. Cancer Vaccines Features
Figure 4. Global mRNA Vaccines for Infectious Diseases Market Share by Application: 2021 VS 2028
Figure 5. Infectious Disease Case Studies
Figure 6. Cancer Case Studies
Figure 7. mRNA Vaccines for Infectious Diseases Report Years Considered
Figure 8. Global mRNA Vaccines for Infectious Diseases Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global mRNA Vaccines for Infectious Diseases Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global mRNA Vaccines for Infectious Diseases Market Share by Region: 2021 VS 2028
Figure 11. Global mRNA Vaccines for Infectious Diseases Market Share by Players in 2021
Figure 12. Global Top mRNA Vaccines for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Infectious Diseases as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by mRNA Vaccines for Infectious Diseases Revenue in 2021
Figure 14. North America mRNA Vaccines for Infectious Diseases Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2028)
Figure 16. North America mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2028)
Figure 17. North America mRNA Vaccines for Infectious Diseases Market Size Share by Country (2017-2028)
Figure 18. United States mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe mRNA Vaccines for Infectious Diseases Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2028)
Figure 22. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2028)
Figure 23. Europe mRNA Vaccines for Infectious Diseases Market Size Share by Country (2017-2028)
Figure 24. Germany mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size Share by Region (2017-2028)
Figure 34. China mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America mRNA Vaccines for Infectious Diseases Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2028)
Figure 42. Latin America mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2028)
Figure 43. Latin America mRNA Vaccines for Infectious Diseases Market Size Share by Country (2017-2028)
Figure 44. Mexico mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size Share by Country (2017-2028)
Figure 50. Turkey mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022)
Figure 54. CureVac Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022)
Figure 55. Translate Bio Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022)
Figure 56. BioNTech Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022)
Figure 57. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022)
Figure 58. Argos Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022)
Figure 59. In-Cell-Art Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022)
Figure 60. eTheRNA Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022)
Figure 61. Ethris Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022)
Figure 62. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Industry Market Size
